Clinical Trial Update: Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT

View source ↗

Summary

A completed clinical trial comparing regadenoson and dipyridamole as pharmacologic stress agents for myocardial perfusion imaging before SPECT. The study by Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Lexiscan (regadenoson)
• Persantine (Dipyridamole)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Myocardial Perfusion Imaging | Status: COMPLETED